During cancer progression, SMAD4 inactivation shifts TGFβ’s activity from tumor-suppressive to tumor-promoting by impairing its ability to trigger cell-cycle arrest and EMT-coupled apoptosis11,12. The gene discussed is SMAD4; the disease is neoplasm.